These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 27504941)
1. Prognostic value of 18F-FDG PET/CT for identifying high- and low-risk endometrial cancer patients. Özgü E; Öz M; Yıldız Y; Özgü BS; Erkaya S; Güngör T Ginekol Pol; 2016; 87(7):493-7. PubMed ID: 27504941 [TBL] [Abstract][Full Text] [Related]
2. Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/CT in Prediction of Uterine Risk Factors and Lymph Node Metastasis: An Analysis of 111 Endometrioid Endometrial Cancer Patients. Konuralp Atakul B; Taşkın S; Soydal Ç; Sükür YE; Kahraman A; Koyuncu K; İbiş E; Ortac F Gynecol Obstet Invest; 2017; 82(4):340-348. PubMed ID: 27771729 [TBL] [Abstract][Full Text] [Related]
3. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer. Kim HJ; Cho A; Yun M; Kim YT; Kang WJ Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Preoperative Imaging: Comparing 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography to Computed Tomography Alone for Preoperative Planning in High-risk Histology Endometrial Carcinoma. St Laurent JD; Davis MR; Feltmate CM; Goodman A; Del Carmen MG; Horowitz NE; Lee SI; Growdon WB Am J Clin Oncol; 2020 Oct; 43(10):714-719. PubMed ID: 32804777 [TBL] [Abstract][Full Text] [Related]
6. The value of primary tumor (18)F-FDG uptake on preoperative PET/CT for predicting intratumoral lymphatic invasion and axillary nodal metastasis. Jung NY; Kim SH; Kang BJ; Park SY; Chung MH Breast Cancer; 2016 Sep; 23(5):712-7. PubMed ID: 26219608 [TBL] [Abstract][Full Text] [Related]
8. Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study. Caobelli F; Alongi P; Evangelista L; Picchio M; Saladini G; Rensi M; Geatti O; Castello A; Laghai I; Popescu CE; Dolci C; Crivellaro C; Seghezzi S; Kirienko M; De Biasi V; Cocciolillo F; Quartuccio N; Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):404-13. PubMed ID: 26381775 [TBL] [Abstract][Full Text] [Related]
9. The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging. Park JY; Lee JJ; Choi HJ; Song IH; Sung CO; Kim HO; Chae SY; Kim YT; Nam JH Ann Surg Oncol; 2017 Aug; 24(8):2303-2310. PubMed ID: 28550488 [TBL] [Abstract][Full Text] [Related]
10. Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer. Lee HJ; Ahn BC; Hong CM; Song BI; Kim HW; Kang S; Jeong SY; Lee SW; Lee J Nuklearmedizin; 2011; 50(5):204-13. PubMed ID: 21727990 [TBL] [Abstract][Full Text] [Related]
11. The value of PET/CT in determining lymph node metastasis of endometrial cancer. Budak E; Yanarateş A Ginekol Pol; 2019; 90(10):565-570. PubMed ID: 31686412 [TBL] [Abstract][Full Text] [Related]
12. The value of preoperative 18F-FDG PET/CT for the assessing contralateral neck in head and neck cancer patients with unilateral node metastasis (N1-3). Joo YH; Yoo IR; Cho KJ; Park JO; Nam IC; Kim CS; Kim SY; Kim MS Clin Otolaryngol; 2014 Dec; 39(6):338-44. PubMed ID: 25102759 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative metabolic tumor volume measured by ¹⁸F-FDG PET/CT and MRI in patients with endometrial cancer. Chung HH; Lee I; Kim HS; Kim JW; Park NH; Song YS; Cheon GJ Gynecol Oncol; 2013 Sep; 130(3):446-51. PubMed ID: 23791826 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of (18)F-FDG PET/CT for axillary lymph node staging in patients with breast cancer. Kitajima K; Fukushima K; Miyoshi Y; Katsuura T; Igarashi Y; Kawanaka Y; Mouri M; Maruyama K; Yamano T; Doi H; Yamakado K; Hirota S; Hirota S Jpn J Radiol; 2016 Mar; 34(3):220-8. PubMed ID: 26715510 [TBL] [Abstract][Full Text] [Related]
15. Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT. Crivellaro C; Signorelli M; Guerra L; De Ponti E; Pirovano C; Fruscio R; Elisei F; Montanelli L; Buda A; Messa C Gynecol Oncol; 2013 Aug; 130(2):306-11. PubMed ID: 23707673 [TBL] [Abstract][Full Text] [Related]
16. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology. Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796 [TBL] [Abstract][Full Text] [Related]
17. Comparison of retrospective PET and MRI-DWI (PET/MRI-DWI) image fusion with PET/CT and MRI-DWI in detection of cervical and endometrial cancer lymph node metastases. Stecco A; Buemi F; Cassarà A; Matheoud R; Sacchetti GM; Arnulfo A; Brambilla M; Carriero A Radiol Med; 2016 Jul; 121(7):537-45. PubMed ID: 27033474 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of lymph node-to-primary tumor standardized uptake value ratio in endometrioid endometrial carcinoma. Chung HH; Cheon GJ; Kim JW; Park NH; Song YS Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):47-55. PubMed ID: 28828510 [TBL] [Abstract][Full Text] [Related]
19. High-grade endometrial cancer: value of [(18)F]FDG PET/CT in preoperative staging. Picchio M; Mangili G; Samanes Gajate AM; De Marzi P; Spinapolice EG; Mapelli P; Giovacchini G; Sigismondi C; Viganò R; Sironi S; Messa C Nucl Med Commun; 2010 Jun; 31(6):506-12. PubMed ID: 20168262 [TBL] [Abstract][Full Text] [Related]